South Africa’s first National Tuberculosis Prevalence Survey found that many people without TB symptoms nevertheless have TB disease that can be detected using chest X-rays. Accordingly, new mobile X-ray screening programmes are being piloted in a number of provinces. Tiyese Jeranji reports.
Following a decline in childhood immunisations during the COVID-19 hard lockdown last year, a nationwide catch-up drive was launched in November. Government is not sharing all the data on how the drive is going, but the data that we have been able to access shows that some important catch-up targets are being missed.
One of the biggest challenges now facing South Africa’s HIV response is how to support many more people living with HIV to engage or re-engage and then stay on treatment. One way to make it easier for people living with HIV to adhere to treatment is to provide a longer supply of medicines, argues Ndivhuwo Rambau & Simphiwe Xaba.
Spotlight first interviewed physician and infectious diseases specialist Dr Arifa Parker in May last year as South Africa’s first wave of COVID-19 was building up. Eleven very difficult months later, Bienne Huisman checks in with Parker to hear how things are going on the frontlines at Tygerberg Hospital.
Biopharmaceuticals are therapeutic drugs, vaccines, and diagnostics in which the active ingredient is produced in a living substance such as eggs or tobacco plants. The living substance acts as a ‘miniature factory’ in which the active ingredient is grown and replicated. Catherine Tomlinson takes a deep dive into the fascinating research and other initiatives in South Africa aimed at spurring local production of these products – and asks why a Cape Town-based company opted to set up a manufacturing plant in Mauritius rather than at home.
Six years after the South African Human Rights Commission held hearings into access to emergency medical services in the Eastern Cape little has changed for the people of Xhora Mouth, writes Phumzile Msaro.
It is a hundred years since the BCG vaccine, the only registered vaccine proven to offer some protection against tuberculosis (TB), was first used in people. Now researchers in South Africa are at the forefront of clinical trials testing experimental new TB vaccines. Adele Baleta reports.
Like with SARS-CoV2, we need to rapidly implement and scale-up effective tuberculosis (TB) prevention interventions, while remaining adaptive to prevailing needs across the country. If we choose to pursue this more deliberate approach to TB prevention in South Africa, World TB Day will no longer be an admission of insufficient progress, but a celebration of defeating our long-standing battle with this curable disease, writes Dr Kavindhran Velen and Professor Salome Charalambous.
It is time to engage communities through community healthcare workers and to leverage COVID-19 innovations to advance the urgent need for high-quality, person-centred tuberculosis (TB) care for all, argue authors from leading TB advocacy organisation TB Proof.
Around 360 000 to 390 000 people in South Africa fall ill with tuberculosis (TB) every year. Of these, around 120 000 to 150 000 are never diagnosed. Now a new TB testing strategy has been shown to improve TB detection at clinics by 17%. Tiyese Jeranji reports.
South Africa is likely headed for a third wave of COVID-19 infections, experts warn. With no windfall of vaccines in sight, many people at high risk of COVID-19 will remain unvaccinated. Now some doctors and medical ethicists are asking: Is a safe vaccine that could possibly protect them better than nothing?
As the first two waves of COVID-19 swept through South Africa hospitals and healthcare workers were under huge pressure. Siyabonga Kamnqa spoke to some medical students about their involvement in a Western Cape volunteer programme to help out at health facilities.
